New Risk • Jun 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$11.8m (US$8.31m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Market cap is less than US$10m (CA$11.8m market cap, or US$8.31m). Minor Risk Large one-off items impacting financial results. Reported Earnings • May 06
Second quarter 2026 earnings released: EPS: CA$0.03 (vs CA$0.002 in 2Q 2025) Second quarter 2026 results: EPS: CA$0.03 (up from CA$0.002 in 2Q 2025). Revenue: CA$17.8m (flat on 2Q 2025). Net income: CA$3.92m (up CA$3.68m from 2Q 2025). Profit margin: 22% (up from 1.3% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 113% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings. Board Change • Mar 13
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jan 31
First quarter 2026 earnings released: EPS: CA$0.005 (vs CA$0.003 in 1Q 2025) First quarter 2026 results: EPS: CA$0.005 (up from CA$0.003 in 1Q 2025). Revenue: CA$19.2m (up 9.3% from 1Q 2025). Net income: CA$565.1k (up 39% from 1Q 2025). Profit margin: 2.9% (up from 2.3% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings. Aankondiging • Jan 08
1CM Inc. Announces Chief Financial Officer Changes, Effective January 7, 2026 1CM Inc. announced that its board of directors has appointed Antony Pramoth as Chief Financial Officer of the company. Mr. Pramoth succeeds Harshil Chovatiya, who has served as the Company's Chief Financial Officer since February 24, 2023, effective January 7, 2026. Mr. Pramoth has been with the company since October 2023. The company is promoted Mr. Pramoth to the role of CFO. Reported Earnings • Dec 31
Full year 2025 earnings released: EPS: CA$0.004 (vs CA$0.005 in FY 2024) Full year 2025 results: EPS: CA$0.004 (down from CA$0.005 in FY 2024). Revenue: CA$73.4m (up 28% from FY 2024). Net income: CA$484.8k (down 21% from FY 2024). Profit margin: 0.7% (down from 1.1% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 114% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings. Board Change • Nov 05
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 24
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 01
Third quarter 2025 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2024) Third quarter 2025 results: EPS: CA$0 (in line with 3Q 2024). Revenue: CA$18.3m (up 22% from 3Q 2024). Net income: CA$45.2k (up CA$63.7k from 3Q 2024). Profit margin: 0.2% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings. Board Change • Jul 28
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jul 07
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jun 20
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jun 05
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 30
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Aankondiging • Apr 23
1CM Inc., Annual General Meeting, Jun 16, 2025 1CM Inc., Annual General Meeting, Jun 16, 2025. Location: ontario, toronto Canada Board Change • Apr 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. CEO & Director Tanvi Bhandari was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Feb 26
High number of new and inexperienced directors There are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Lucas Leone is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Board Change • Feb 04
High number of new and inexperienced directors There are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Lucas Leone is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jan 01
Full year 2024 earnings released: EPS: CA$0.005 (vs CA$0.008 loss in FY 2023) Full year 2024 results: EPS: CA$0.005 (up from CA$0.008 loss in FY 2023). Revenue: CA$57.2m (up 62% from FY 2023). Net income: CA$615.9k (up CA$1.53m from FY 2023). Profit margin: 1.1% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Board Change • Nov 26
High number of new and inexperienced directors There are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Lucas Leone is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 01
Third quarter 2024 earnings released: EPS: CA$0 (vs CA$0.006 loss in 3Q 2023) Third quarter 2024 results: EPS: CA$0 (improved from CA$0.006 loss in 3Q 2023). Revenue: CA$15.0m (up 73% from 3Q 2023). Net loss: CA$18.4k (loss narrowed 97% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • May 01
Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2023) Second quarter 2024 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2023). Revenue: CA$13.3m (up 73% from 2Q 2023). Net loss: CA$13.7k (loss narrowed 97% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. New Risk • Apr 19
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CA$117.7m (US$85.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-CA$4.7m). Share price has been volatile over the past 3 months (18% average weekly change). Shareholders have been diluted in the past year (2.9% increase in shares outstanding). Market cap is less than US$100m (CA$117.7m market cap, or US$85.5m). New Risk • Mar 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-CA$4.7m). Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (2.9% increase in shares outstanding). Reported Earnings • Jan 30
First quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.003 profit in 1Q 2023) First quarter 2024 results: CA$0.003 loss per share (down from CA$0.003 profit in 1Q 2023). Revenue: CA$12.3m (up 66% from 1Q 2023). Net loss: CA$405.3k (down 215% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Dec 31
Full year 2023 earnings released: CA$0.008 loss per share (vs CA$0.054 loss in FY 2022) Full year 2023 results: CA$0.008 loss per share (improved from CA$0.054 loss in FY 2022). Revenue: CA$35.3m (up CA$34.5m from FY 2022). Net loss: CA$913.9k (loss narrowed 81% from FY 2022). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 83% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Sep 26
1Cm Inc. Expands its Operations Adding Tobacco, CPG, Private Label Products 1CM Inc. announce the addition of Tobacco, Vape & Consumer Packaged Goods products to its retail portfolio. 1CM has begun retailing cigarettes and vape products as an authorized retailer of Imperial Tobacco Canada Ltd. A wholly owned subsidiary of British American Tobacco and Rothmans Benson & Hedges Inc. A wholly owned subsidiary of Altria (formerly Philip Morris International). These products are purchased directly from the manufacturers. 1CM has further begun retailing complimentary CPG products from Pepsi, Frito-Lay, Parmalat & Canada Bread. The products are distributed to the company from Arctic Beverages. 1CM has also begun producing its private label Vodka and Vodka Iced Tea. Under the brand "EPIC MILFF". These products are manufactured in collaboration with Minhas Sask Ventures Inc. This strategic horizontal expansion marks a significant milestone for the 1CM as it now extends its operations to Tobacco, CPG and Private Label products. 1CM will continue to leverage its technology to warehouse, mine and obtain insights from the valuable data obtained from its retail customers of Cannabis, Liquor, Tobacco, & CPG products. This data will allow the company to determine channel complementarity and provide unique cross-channel marketing opportunities and experiences to the age-gated 1CM customers. In industries like Tobacco and Cannabis with strict regulations around marketing, this provides an invaluable resource to 1CM and the tobacco industry as they will have a compliant marketing opportunity, supported by high quality data on purchasing patterns across multiple channels. 1CM is building a reputation in the liquor retail industry for its commitment to exceptional customer service, and value. These new product offerings will improve the customer experience and increase revenues. Reported Earnings • Aug 01
Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.012 loss in 3Q 2022) Third quarter 2023 results: CA$0.006 loss per share (improved from CA$0.012 loss in 3Q 2022). Revenue: CA$8.70m (up CA$8.47m from 3Q 2022). Net loss: CA$670.2k (loss narrowed 38% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has increased by 110% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Aug 01
1CM Inc. (CNSX:EPIC) acquired Fresh Cannabis Co. Inc. from Cost Cannabis Inc. for CAD 0.38 million. 1CM Inc. (CNSX:EPIC) acquired Fresh Cannabis Co. Inc. from Cost Cannabis Inc. for CAD 0.38 million on December 1, 2022.1CM Inc. (CNSX:EPIC) completed the acquisition of Fresh Cannabis Co. Inc. from Cost Cannabis Inc. on December 1, 2022. Reported Earnings • May 03
Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.012 loss in 2Q 2022) Second quarter 2023 results: CA$0.004 loss per share (improved from CA$0.012 loss in 2Q 2022). Revenue: CA$7.69m (up CA$7.39m from 2Q 2022). Net loss: CA$483.5k (loss narrowed 55% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has increased by 105% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Dec 29
Full year 2022 earnings released: CA$0.054 loss per share (vs CA$0.055 loss in FY 2021) Full year 2022 results: CA$0.054 loss per share. Net loss: CA$4.78m (loss widened 2.6% from FY 2021). Aankondiging • Dec 29
1CM Inc. (CNSX:EPIC) acquired remaining 35% stake of LCG Holdings, Inc. 1CM Inc. (CNSX:EPIC) acquired remaining 35% stake of LCG Holdings, Inc. in July, 2022.1CM Inc. (CNSX:EPIC) completed the acquisition of remaining 35% stake of LCG Holdings, Inc. in July, 2022. Board Change • Nov 16
High number of new and inexperienced directors There are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Independent Director Lucas Leone is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Aankondiging • Nov 10
1CM Inc. announced that it expects to receive CAD 5.8 million in funding 1CM Inc announced a non-brokered private placement of 4,000,000 common shares at a price of CAD 1.45 per share for gross proceeds of up to CAD 5,800,000 to certain accredited investors on November 9, 2022. All securities issued are subject to a statutory four month hold period. Reported Earnings • Jul 30
Third quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 3Q 2021) Third quarter 2022 results: CA$0.012 loss per share (down from CA$0.011 loss in 3Q 2021). Revenue: CA$235.3k (up 42% from 3Q 2021). Net loss: CA$1.08m (loss widened 17% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth. Aankondiging • Jul 09
Leviathan Natural Products Inc., Annual General Meeting, Sep 06, 2022 Leviathan Natural Products Inc., Annual General Meeting, Sep 06, 2022. Aankondiging • Jun 10
Leviathan Natural Products Inc. (CNSX:EPIC) acquired One Cannabis Market Inc. for CAD 0.52 million. Leviathan Natural Products Inc. (CNSX:EPIC) acquired One Cannabis Market Inc. for CAD 0.52 million on June 9, 2022. As part of consideration Leviathan Natural will pay CAD 0.5 million common shares. Kamyar Hosseini will join Leviathan as head of technology. The Issued Shares shall be subject to restrictions on resale or transfer.
Leviathan Natural Products Inc. (CNSX:EPIC) completed the acquisition of One Cannabis Market Inc. on June 9, 2022. Reported Earnings • May 01
Second quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 2Q 2021) Second quarter 2022 results: CA$0.012 loss per share (down from CA$0.011 loss in 2Q 2021). Revenue: CA$300.8k (up 189% from 2Q 2021). Net loss: CA$1.07m (loss widened 11% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Lucas Leone is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Reported Earnings • Jan 30
First quarter 2022 earnings: Revenues and EPS in line with analyst expectations First quarter 2022 results: CA$0.012 loss per share (down from CA$0.011 loss in 1Q 2021). Revenue: CA$228.1k (up 313% from 1Q 2021). Net loss: CA$991.0k (loss widened 10% from 1Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Board Change • Jan 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director R. Jarvis was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 03
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Independent Director R. Jarvis was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Aankondiging • Aug 18
Leviathan Natural Products Inc. (CNSX:EPIC) acquired Natural Origins SAS for approximately COP 500 million Leviathan Natural Products Inc. (CNSX:EPIC) signed a share purchase agreement to acquire Natural Origins SAS for approximately COP 500 million on December 7, 2020.
Leviathan Natural Products Inc. (CNSX:EPIC) completed the acquisition of Natural Origins SAS on August 6, 2021. Is New 90 Day High Low • Mar 02
New 90-day high: CA$0.52 The company is up 247% from its price of CA$0.15 on 27 November 2020. The Canadian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 39% over the same period. Is New 90 Day High Low • Feb 05
New 90-day high: CA$0.48 The company is up 200% from its price of CA$0.16 on 06 November 2020. The Canadian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 71% over the same period. Is New 90 Day High Low • Jan 21
New 90-day high: CA$0.36 The company is up 118% from its price of CA$0.17 on 21 October 2020. The Canadian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 73% over the same period. Is New 90 Day High Low • Dec 31
New 90-day high: CA$0.22 The company is up 22% from its price of CA$0.18 on 01 October 2020. The Canadian market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Pharmaceuticals industry, which is up 57% over the same period. Is New 90 Day High Low • Dec 22
New 90-day high: CA$0.21 The company is up 10.0% from its price of CA$0.20 on 16 September 2020. The Canadian market is also up 10.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Pharmaceuticals industry, which is up 50% over the same period.